Medicine
Dietary Supplement Health and Education Act (DSHEA)
Quick fact
Before DSHEA in 1994, the FDA treated dietary supplements mostly as foods—but the law carved out a new category that prohibits the FDA from requiring proof of safety before a supplement is sold.
Why this is interesting
You've probably seen shelves full of vitamins, herbal remedies, and protein powders. But do you know why these products are sold with little to no government approval before they hit the market?
Read the full explanation
Understanding Dietary Supplement Health and Education Act (DSHEA)
Imagine you want to create a new breakfast cereal. You have to follow food safety rules. Now imagine you want to sell a new vitamin pill. Under DSHEA, you don't need to prove it's safe before selling it—the government has to prove it's unsafe to remove it from shelves. That's a huge difference. DSHEA was passed to ensure consumers have access to supplements while giving the FDA authority to act against dangerous products after they are on the market. The law defines a dietary supplement as a product (apart from tobacco) intended to supplement the diet that contains one or more dietary ingredients (vitamins, minerals, herbs, amino acids, etc.) and is labeled as a dietary supplement. It also sets rules for what kind of health claims can be made on labels, distinguishing between 'structure/function' claims and 'disease claims'.
A deeper explanation
The DSHEA works by placing dietary supplements into a distinct regulatory category. The key mechanism is the burden of proof: under DSHEA, the FDA must show that a supplement presents a 'significant or unreasonable risk of illness or injury' before it can restrict its sale. This contrasts with drugs, where manufacturers must prove both safety and efficacy before marketing. DSHEA also prohibits the FDA from requiring pre-market approval for supplements, but it does require that supplement labels be informative (e.g., a Supplement Facts panel) and that claims be truthful and not misleading. Importantly, if a supplement makes a disease claim (e.g., 'cures cancer'), it becomes subject to drug regulations. The law matters because it balances consumer access with safety, but critics argue it leaves consumers vulnerable to harmful or mislabeled products. Understanding DSHEA is essential for anyone evaluating supplement information, recognizing that caveat emptor (buyer beware) largely applies.